Skip Ribbon Commands
Skip to main content
Menu
Dr Htay Htay

Dr Htay Htay

MBBS (Yangon), MMed (S'pore), FRCP (Edin)

Senior Consultant

Singapore General Hospital

Specialty: Renal Medicine

Sub-specialties: Peritoneal Dialysis

Conditions Treated by this Doctor:
Acid Base Disorders, Fluid & Electrolytes, Haemodialysis - Acute and Chronic, Insertion of Non-tunneled Hemodialysis Catheter, Renal Biopsy, Renal Biopsy, Renal Clearance Studies, Renal Retardation, Renal Stone Disease, Renal Transplant.

Clinical Appointments

  • Senior Consultant Renal Medicine Singapore General HospitalSingapore General Hospital

Profile

Dr Htay Htay is an accredited nephrologist at Department of Renal Medicine, Singapore General Hospital. She graduated from University of Medicine (1) Yangon, Myanmar and received Master of Medicine (Internal medicine) from the National University of Singapore. She completed her basic specialist training in Internal Medicine and advanced specialist training in Nephrology at Singapore General Hospital. She received Health Manpower Development Programme (HMDP) Award and underwent fellowship training at Princess Alexandra Hospital, Brisbane, Australia. She is also a member of Royal College of Physician, International Society of Peritoneal Dialysis, and Singapore Society of Nephrology.

Education

  • MBBS (Yangon) 
  • M.Med (S'pore) 
  • MRCP (UK)

Professional Appointments and Committee Memberships

  • Senior Consultant, Department of Renal medicine, Singapore General Hospital 
  • Department Quality Officer (2017-2019) 
  • Member, Singapore Society of Nephrology 
  • Member, International Society for Peritoneal Dialysis 
  • Clinical tutor at National University of Singapore, Yong Loo Lin School of Medicine since 2011 
  • Visiting lecturer for Advanced Diploma in Nursing in Nanyang Polytechnic since 2015

Awards

  •  Health Manpower Development Programme (HMDP) Award (2015)

Research Interests

  • Patients with chronic kidney disease
  • Peritoneal dialysis

Publications

  • Comparison of topical chlorhexidine and mupirocin for the prevention of exit-site infection in incident peritoneal dialysis patients
    Htay H, Johnson DW, Wu SY, Oei EL, Foo MWY, Choo JCJ
    Peritoneal Dialysis International, Vol. 37, pp. 283–289
  • Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ trial
    Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW on behalf of the balANZ Trial Investigators
    Peritoneal Dialysis International, Vol. 37, pp. 266–272
  • Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis
    Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley CM, Clayton PA, Borlace M, Badve SV, Kamal Sud, Boudville N, McDonald SP, Johnson DW
    Clinical Journal of the American Society of Nephrology (In press; Acceptance date 19 April 2017)  
  • Outcomes of Corynebacterium peritonitis: a multi-centre registry analysis.
    Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Clayton PA, Borlace M, Badve SV, Kamal Sud, Boudville N, McDonald SP, Johnson DW.
    Peritoneal Dialysis International, (In press; Acceptance date 2 May 2017

Research Trials